创伤性脑损伤合并失血性休克患者可从全血复苏中获益
该研究为前瞻性观察性队列研究的事先设定亚组,纳入2017年11月至2020年9月期间头部简明损伤定级≥3的成人创伤患者,比较接受全血(WB)与仅接受成分血(COMP)复苏者的结局。在564例合格患者中,341例接受WB;WB组损伤严重度评分更高(中位数34 vs. 29)、现场血压更低(104 vs. 118)、到达时乳酸更高(4.3 vs. 3.6,均p < 0.05)。单因素分析显示两组总体死亡率相似,但加权多因素分析发现WB与总体死亡率和TBI相关死亡率降低相关,两组出院去向无差异。作者认为,在创伤性脑损伤合并失血性休克患者中,全血应被视为出血的一线治疗。
要点
- 在创伤性脑损伤(头部简明损伤定级≥3)合并失血性休克成人患者中,加权多因素分析显示全血复苏与总体死亡率降低相关。
- 同一加权多因素分析显示,全血复苏与TBI相关死亡率降低相关。
- 单因素分析中全血组与成分血组总体死亡率相似,组间出院去向(回家或康复机构)无差异。
- WB组损伤严重度评分更高(中位数34 vs. 29)、现场血压更低(104 vs. 118)、到达时乳酸更高(4.3 vs. 3.6,均p < 0.05)。
- 作者结论认为,全血应被视为创伤性脑损伤背景下出血的一线治疗。
适用人群与场景
- 成人创伤患者,于2017年11月至2020年9月就诊,头部简明损伤定级≥3(定义为TBI),因失血性休克接受紧急发放血制品。
- 全血组患者接受任何冷藏低效价O型全血单位;成分血组仅接受分馏血制品。
诊断标准与关键阈值
- TBI定义:头部简明损伤定级≥3。
- 全血组:接受任何冷藏低效价O型全血单位。
- 成分血组:仅接受分馏血制品。
研究设计与关键结果
- 研究类型:前瞻性观察性队列研究的事先设定亚组;合格患者564例,其中341例接受WB。
- WB组与COMP组比较:损伤严重度评分中位数34 vs. 29,现场血压104 vs. 118,到达时乳酸4.3 vs. 3.6(均p < 0.05)。
- 单因素分析:WB组与COMP组总体死亡率相似。
- 加权多因素分析:WB与总体死亡率降低相关,并与TBI相关死亡率降低相关。
- WB组与COMP组出院去向(回家或康复机构)无差异。
证据类型、等级与局限
- 证据类型:前瞻性观察性队列研究的事先设定亚组分析;证据等级:治疗/临床管理;Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在创伤性脑损伤合并失血性休克患者中,全血应被视为出血的一线治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hemorrhagic shock in the setting of traumatic brain injury (TBI) reduces cerebral blood flow and doubles mortality. The optimal resuscitation strategy for hemorrhage in the setting of TBI is unknown. We hypothesized that, among patients presenting with concomitant hemorrhagic shock and TBI, resuscitation including whole blood (WB) is associated with decreased overall and TBI-related mortality when compared with patients receiving component (COMP) therapy alone.
METHODS: An a priori subgroup of prospective, observational cohort study of injured patients receiving emergency-release blood products for hemorrhagic shock is reported. Adult trauma patients presenting November 2017 to September 2020 with TBI, defined as a Head Abbreviated Injury Scale of ≥3, were included. Whole blood group patients received any cold-store low-titer Group O WB units. The COMP group received fractionated blood components alone. Overall and TBI-related 30-day mortality, favorable discharge disposition (home or rehabilitation), and 24-hour blood product utilization were assessed. Univariate and inverse probabilities of treatment-weighted multivariable analyses were performed.
RESULTS: Of 564 eligible patients, 341 received WB. Patients who received WB had a higher injury severity score (median, 34 vs. 29), lower scene blood pressure (104 vs. 118), and higher arrival lactate (4.3 vs. 3.6, all p < 0.05). Univariate analysis noted similar overall mortality between WB and COMP; however, weighted multivariable analyses found WB was associated with decreased overall mortality and TBI-related mortality. There were no differences in discharge disposition between the WB group and COMP group.
CONCLUSION: In patients with concomitant hemorrhagic shock and TBI, WB transfusion was associated with decreased overall mortality and TBI-related mortality. Whole blood should be considered a first-line therapy for hemorrhage in the setting of TBI.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Hatton GE, Brill JB, Tang B, et al. Patients with both traumatic brain injury and hemorrhagic shock benefit from resuscitation with whole blood. J Trauma Acute Care Surg. 2023. PMID: 37506356. doi:10.1097/TA.0000000000004110
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。